Shizhong Zhang1,2, Yanyan Hu3, Zhen Li2, Dezhang Huang1, Mingran Zhang2, Chenglong Wang1, Zhigang Wang1. 1. Department of Neurosurgery, Qilu Hospital of Shandong University NO. 758, Hefei Road, Shibei District, Qingdao 266035, Shangdong, China. 2. Department of Neurosurgery, Taian Central Hospital NO. 29, Longtan Road, Taian 271000, Shangdong, China. 3. Color Ultrasonic Room, Taian Central Hospital NO. 29, Longtan Road, Taian 271000, Shangdong, China.
Abstract
AIM: We experienced a series of patients with hemorrhagic CVST, who were successfully treated with endovascular treatment (EVT). The aim was to explore the best scheme for the future through our treatment data of hemorrhagic CVST. MATERIAL AND METHODS: A retrospective analysis was conducted, selecting nine hemorrhagic CVST patients, who were mainly treated with EVT. Characteristics of hemorrhagic CVST were recorded, including risk factors, thrombus location, presenting symptoms, and treatment details included type of EVT. We also recorded clinical outcomes, degree of sinus recanalization, thrombus recurrences, periprocedural complications, degree of neurological deficit at last follow-up. RESULTS: Catheter thrombolysis and mechanical thrombectomy were applied in all of the nine hemorrhagic CVST patients, stent retriever was used in 7 patients, one of them combined with balloon-assisted thrombectomy. Besides EVT, two patients accepted emergency surgical decompression, one in the local hospital, and the other in our hospital. The follow-up duration ranged from 4 to 28 months. All of them have a neurological and symptomatic improvement, 6 patients have a good outcome, the rest 3 patients have a poor outcome, no thrombus recurrences and death in them. Seven patients had complete recanalization and two patients had partial recanalization at last follow-up. CONCLUSION: EVT is an effective and safe procedure for potentially catastrophic hemorrhagic cerebral venous sinus thrombosis.
AIM: We experienced a series of patients with hemorrhagic CVST, who were successfully treated with endovascular treatment (EVT). The aim was to explore the best scheme for the future through our treatment data of hemorrhagic CVST. MATERIAL AND METHODS: A retrospective analysis was conducted, selecting nine hemorrhagic CVST patients, who were mainly treated with EVT. Characteristics of hemorrhagic CVST were recorded, including risk factors, thrombus location, presenting symptoms, and treatment details included type of EVT. We also recorded clinical outcomes, degree of sinus recanalization, thrombus recurrences, periprocedural complications, degree of neurological deficit at last follow-up. RESULTS:Catheter thrombolysis and mechanical thrombectomy were applied in all of the nine hemorrhagic CVST patients, stent retriever was used in 7 patients, one of them combined with balloon-assisted thrombectomy. Besides EVT, two patients accepted emergency surgical decompression, one in the local hospital, and the other in our hospital. The follow-up duration ranged from 4 to 28 months. All of them have a neurological and symptomatic improvement, 6 patients have a good outcome, the rest 3 patients have a poor outcome, no thrombus recurrences and death in them. Seven patients had complete recanalization and two patients had partial recanalization at last follow-up. CONCLUSION:EVT is an effective and safe procedure for potentially catastrophic hemorrhagic cerebral venous sinus thrombosis.
Authors: K Einhäupl; M-G Bousser; S F T M de Bruijn; J M Ferro; I Martinelli; F Masuhr; J Stam Journal: Eur J Neurol Date: 2006-06 Impact factor: 6.089
Authors: Fazeel M Siddiqui; Sudeepta Dandapat; Chirantan Banerjee; Susanna M Zuurbier; Mark Johnson; Jan Stam; Jonathan M Coutinho Journal: Stroke Date: 2015-04-21 Impact factor: 7.914
Authors: K Einhäupl; J Stam; M-G Bousser; S F T M De Bruijn; J M Ferro; I Martinelli; F Masuhr Journal: Eur J Neurol Date: 2010-10 Impact factor: 6.089
Authors: José M Ferro; Patrícia Canhão; Jan Stam; Marie-Germaine Bousser; Fernando Barinagarrementeria Journal: Stroke Date: 2004-02-19 Impact factor: 7.914
Authors: Philipp Bücke; Victoria Hellstern; Alexandru Cimpoca; José E Cohen; Thomas Horvath; Oliver Ganslandt; Hansjörg Bäzner; Hans Henkes Journal: J Clin Med Date: 2022-07-20 Impact factor: 4.964
Authors: Alexandre Simonin; Marco Rusca; Guillaume Saliou; Marc Levivier; Roy Thomas Daniel; Mauro Oddo Journal: Neurocrit Care Date: 2019-10 Impact factor: 3.210